Lenvatinib plus pembrolizumab in patients with either treatment-naive or previously treated metastatic renal cell carcinoma (Study 111/KEYNOTE-146): a phase 1b/2 study

Chung Han Lee, Amishi Yogesh Shah, Drew Rasco, Arpit Rao, Matthew H. Taylor, Christopher Di Simone, James J. Hsieh, Alvaro Pinto, David R. Shaffer, Regina Girones Sarrio, Allen Lee Cohn, Nicholas J. Vogelzang, Mehmet Asim Bilen, Sara Gunnestad Ribe, Musaberk Goksel, Øyvind Krohn Tennøe, Donald Richards, Randy F. Sweis, Jay Courtright, Daniel HeinrichSharad Jain, Jane Wu, Emmett V. Schmidt, Rodolfo F. Perini, Peter Kubiak, Chinyere E. Okpara, Alan D. Smith, Robert J. Motzer

Research output: Contribution to journal › Article › peer-review

106 Scopus citations

Fingerprint

Dive into the research topics of 'Lenvatinib plus pembrolizumab in patients with either treatment-naive or previously treated metastatic renal cell carcinoma (Study 111/KEYNOTE-146): a phase 1b/2 study'. Together they form a unique fingerprint.

Medicine & Life Sciences